SPINAL MUSCLE ATROPHY

Clinical trials for SPINAL MUSCLE ATROPHY explained in plain language.

Never miss a new study

Get alerted when new SPINAL MUSCLE ATROPHY trials appear

Sign up with your email to follow new studies for SPINAL MUSCLE ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New study tracks Risdiplam's Real-World impact on spinal muscle atrophy

Disease control Not yet recruiting

This study follows 30 people with Type I or Type II spinal muscle atrophy who are starting or have started treatment with risdiplam. Researchers will track motor function improvements and safety over 24 months using standard tests. The goal is to see how well the drug works in ev…

Matched conditions: SPINAL MUSCLE ATROPHY

Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated May 17, 2026 05:03 UTC

SPINAL MUSCLE ATROPHY

Get alerted when new SPINAL MUSCLE ATROPHY trials appear

New study tracks Risdiplam's Real-World impact on spinal muscle atrophy